| Patents for C07H 11 - Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof (1,722) |
|---|
| 04/12/1994 | CA1328450C Sulfated oligosaccharides and derivatives thereof |
| 03/31/1994 | WO1994006438A1 Adenosine analogues and method of increasing adenosine release |
| 03/29/1994 | US5298616 Oligosaccharide contains a maximum of 6 monosaccharide units and at least one metal-sulfonate per monosaccharide unit |
| 03/29/1994 | US5298494 Monosaccharides having anti-proliferation and anti-inflammatory activity, compositions and uses thereof |
| 03/22/1994 | US5296620 Hexenol derivatives as intermediates for compounds for treatment of AIDS virus infections |
| 03/22/1994 | US5296594 Sialic acid glycosides, antigens, immunoadsorbents, and methods for their preparation |
| 03/16/1994 | EP0586570A1 Backbone modified oligonucleotide analogues |
| 03/16/1994 | EP0586520A1 Backbone modified oligonucleotide analogs |
| 03/02/1994 | EP0584175A1 Sulfated glycolipids, containing a galactose-3-0-sulfate moiety, and specific catchers therefor for use in the prophylaxis or therapy of prediabetes, diabetes and/or associated complications in an individual |
| 02/22/1994 | US5288859 Process for the preparation of glycosyl azides |
| 02/16/1994 | EP0582665A1 Sulfated polysaccharides as inhibitors of smooth muscle cell proliferation |
| 02/15/1994 | US5286718 Administering monophosphoryl lipid A or its 3-deacylated derivative |
| 02/03/1994 | WO1994002624A1 A facile enzymatic synthesis of galactosyl-beta-1,3 glycals |
| 02/03/1994 | WO1994002495A1 Esterification process |
| 02/03/1994 | CA2141301A1 Esterification process |
| 01/25/1994 | US5281710 Dynemicin analogs: synthesis, methods of preparation and use |
| 01/25/1994 | CA1326443C Hemorrhoidal, other compositions and methods of treatment |
| 01/20/1994 | DE4223552A1 Glycoside cpd. e.g. neuraminic acid deriv. prepn. - from phosphate or phosphate deriv. glycosyl donor and glycosyl acceptor, giving e.g. ganglioside intermediate |
| 01/11/1994 | US5278301 Route to glycals in the allal and gulal series |
| 01/11/1994 | US5278300 4,6-o-hydroxyphosphoryl-glucosamine derivatives |
| 01/06/1994 | WO1994000596A1 Acceptor for fucosyltransferase |
| 01/06/1994 | WO1994000477A1 Substituted lactose derivatives as cell adhesion inhibitors |
| 01/06/1994 | WO1994000476A1 Use of water-soluble sucroses for the treatment and/or prevention of lesion or inflammation in the digestive tract |
| 01/06/1994 | CA2138645A1 Substituted lactose derivatives as cell adhesion inhibitors |
| 01/06/1994 | CA2137008A1 Acceptor for fucosyltransferase |
| 01/05/1994 | EP0577302A1 Process for preparing alpha-anomer enriched 2-deoxy-2,2-difluoro-D-ribofuranosyl sulfonates |
| 01/05/1994 | EP0394262B1 Platinum compounds suitable for use as pharmaceuticals |
| 01/04/1994 | US5276159 Dynemicin analogs: syntheses, methods of preparation and use |
| 12/29/1993 | EP0576232A1 Process for separating 2-deoxy-2, 2-difluoro-D-ribofuranosyl alkylsulfonate anomers |
| 12/29/1993 | EP0576229A1 Low temperature process for preparing alpha-anomer enriched 2-deoxy-2, 2-difluoro-D-ribofuranosyl sulfonates |
| 12/29/1993 | EP0576228A1 Process for preparing beta-anomer enriched 2-deoxy-2,2-difluoro-D-ribofuranosyl-arylsulfonates |
| 12/28/1993 | US5273993 Compounds having one or more aminosulfonyloxy radicals useful as pharmaceuticals |
| 12/15/1993 | EP0574256A1 Imidate derivatives of pharmaceutically useful anticonvulsant sulfamates |
| 12/09/1993 | WO1993024503A1 Sequential removal of monosaccharides from the reducing end of oligosaccharides and uses thereof |
| 11/25/1993 | WO1993023046A1 Enantiomeric cynemicin analogs, preparation and use thereof |
| 11/25/1993 | CA2136234A1 Enantiomeric dynemicin analogs, preparation and use thereof |
| 11/24/1993 | EP0570682A1 Synthetic lipid A glycoconjugate antigens for use in vaccines |
| 11/23/1993 | US5264586 Analogs of calicheamicin gamma1I, method of making and using the same |
| 11/11/1993 | WO1993022670A1 Phosphorylated contrast agents for mri of the gi tract |
| 11/11/1993 | CA2133746A1 Phosphorylated contrast agents for mri of the gi tract |
| 11/08/1993 | CA2095588A1 Synthetic lipid a glycoconjugate antigens for use in vaccines |
| 11/03/1993 | EP0568306A1 Anticonvulsant fructopyranose cyclic sulfites and sulfates |
| 11/02/1993 | US5258402 Imidate derivatives of sulfamates |
| 10/26/1993 | US5256798 Process for preparing alpha-anomer enriched 2-deoxy-2,2-difluoro-D-ribofuranosyl sulfonates |
| 10/26/1993 | US5256797 Treating mixture with solvent, heating, adding countersolvent, cooling |
| 10/26/1993 | CA1323626C Synthesis of intermediate useful in the preparation of nojirimycin and related compounds |
| 10/20/1993 | EP0404792B1 Use of sulphated sucrose in preparations for the treatment of teeth and their supporting tissue |
| 10/12/1993 | US5252756 Process for preparing beta-anomer enriched 2-deoxy-2,2-difluoro-D-ribofuranosyl-arylsulfonates |
| 09/30/1993 | WO1993018777A1 Use of mannose phosphates for the treatment of fibrotic disorders |
| 09/28/1993 | US5248779 From idofuranose derivative |
| 09/22/1993 | EP0561523A2 Sugar compound, sialic acid-containing sugar chains' biosynthesis inhibitor, production process thereof and intermediate |
| 09/15/1993 | EP0560409A2 Sialic acid glycosides, antigens, immunoadsorbents, and methods for their preparation |
| 09/15/1993 | EP0560055A1 Immuno-suppressing enepyranose derivatives |
| 09/15/1993 | EP0409999B1 Liquid preparation for intraocular perfusion |
| 09/12/1993 | WO1993024506A1 IMMUNOSUPPRESSIVE AND TOLEROGENIC MODIFIED LEWISC AND LacNAc COMPOUNDS |
| 09/12/1993 | CA2118405A1 Immunosuppressive and tolerogenic modified lewisc and lacnac compounds |
| 09/07/1993 | US5242942 Anticonvulsant fructopyranose cyclic sulfites and sulfates |
| 09/01/1993 | CN1075635A Immuno-suppressing agent |
| 07/27/1993 | US5231185 Amidooximes |
| 07/21/1993 | CN1021629C Medicine compound of non-suspending agent and stable sucralfate suspending liquid |
| 07/20/1993 | US5229523 Glycosidase inhibitors |
| 07/13/1993 | US5227479 Process for the preparation of nojirimycin and related compounds |
| 07/08/1993 | WO1993012778A1 Method and composition for ameliorating tissue damage due to ischemia and reperfusion |
| 07/07/1993 | EP0549794A1 Stock solution of sucralfate suspended in water and production thereof |
| 07/07/1993 | EP0549597A1 Anionic furanose derivatives, methods of making and using the same |
| 06/02/1993 | EP0543889A1 Incorporation of selectably clevable and/or abasic sites into oligonucleotide chains and reagents therefor |
| 06/01/1993 | US5216145 Asymmetric synthesis of 3-substituted furanoside compounds |
| 05/27/1993 | WO1993010137A1 2'-deoxy-2'-fluorocoformycin and stereoisomers thereof |
| 05/12/1993 | EP0540807A1 Asymmetric synthesis of 3-substituted furanoside compounds |
| 05/05/1993 | CN1071668A Anti-endotoxin compounds |
| 04/29/1993 | WO1993008205A1 Production of fucosylated carbohydrates by enzymatic fucosylation synthesis of sugar nucleotides; and in situ regeneration of gdp-fucose |
| 04/20/1993 | CA1316532C Process for the chlorination of sugars |
| 04/14/1993 | EP0536969A2 Anti-endotoxin compounds |
| 04/12/1993 | CA2079971A1 Anti-endotoxin compounds and related molecules and methods |
| 04/06/1993 | US5200523 Synthesis of nojirimycin derivatives |
| 03/24/1993 | EP0376959B1 Platinum pharmaceuticals |
| 03/16/1993 | US5194446 Compounds having one or more aminosulfaonyloxy radicals useful as pharmaceuticals |
| 03/03/1993 | EP0529715A1 Sulfated glycosaminoglycanoid derivatives |
| 02/23/1993 | CA1313867C Pentasaccharides |
| 02/04/1993 | WO1993002091A1 Monosaccharide analog-based glycosidase inhibitors |
| 02/04/1993 | WO1993001810A1 ANALOGS OF CALICHEAMICIN η1I, METHOD OF MAKING AND USING THE SAME |
| 01/07/1993 | WO1992021655A3 2-methyl-5-hydroxymethyl- and 2,5-dimethyl-3,4-dihydroxypyrrolidines |
| 12/10/1992 | WO1992021688A1 New perfluoroalkylated amphiphilic phosphorus compounds: preparation and biomedical applications |
| 12/10/1992 | WO1992021655A2 2-methyl-5-hydroxymethyl- and 2,5-dimethyl-3,4-dihydroxypyrrolidines |
| 12/02/1992 | CN1066658A Asymmetric synthesis of 3-substituted furanoside compounds |
| 11/26/1992 | WO1992020823A1 Backbone modified oligonucleotide analogs |
| 11/26/1992 | WO1992020822A1 Backbone modified oligonucleotide analogues |
| 11/26/1992 | CA2103378A1 Backbone modified oligonucleotide analogues |
| 11/24/1992 | US5166212 Certain n-substituted butyramide derivatives |
| 11/22/1992 | CA2103464A1 Backbone modified oligonucleotide analogs |
| 11/17/1992 | CA1310271C Antiulcer composition |
| 11/12/1992 | WO1992019633A1 Sulfated glycolipids, containing a galactose-3-0-sulfate moiety, and specific catchers therefor for use in the prophylaxis or therapy of prediabetes, diabetes and/or associated complications in an individual |
| 11/11/1992 | CA2068226A1 Asymmetric synthesis of 3-substituted furanoside compounds |
| 10/29/1992 | DE4113327A1 New bi:cyclic oxazolidinone carbohydrate derivs. - useful in selective synthesis of diastereomers of chiral N-acyl analogues |
| 10/27/1992 | US5158939 Administering a nontoxic lipopolysaccharide from rhodopseudomonas which negate the inhibitory effects of thymus derived T suppressor cells |
| 10/18/1992 | WO1992018546A1 Sulfated polysaccharides as inhibitors of smooth muscle cell proliferation |
| 10/18/1992 | CA2108569A1 Sulfated polysaccharides as inhibitors of smooth muscle cell proliferation |
| 10/07/1992 | EP0506772A1 A pharmaceutical composition comprising a phosphosugar |
| 10/06/1992 | US5153000 Phosphate, liposome comprising the phosphate as membrane constituent, and cosmetic and liposome preparation comprising the liposome |
| 10/06/1992 | US5152928 Surfactant and method for producing the same |